SCHEMBL5885173

SCHEMBL5885173

COc1c[c]ccc1C(=O)NCCO

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.45
HPGD P15428 5/20 0.43
ALDH1A1 P00352 5/20 0.43
POLB P06746 1/20 0.43
SMPD1 P17405 1/20 0.41
TP53 P04637 1/20 0.41
GLA P06280 1/20 0.41
KDM4E B2RXH2 2/20 0.40
MAPT P10636 2/20 0.40
HSD17B10 Q99714 1/20 0.40
GAA P10253 1/20 0.40
HCRTR1 O43613 1/20 0.40
CTSD P07339 1/20 0.40
KCNA3 P22001 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL182862 0.80 PLK1 (0.49) HPGDALDH1A1TP53GLAMAPT
SCHEMBL182737 0.76 KDM4E (0.44) HPGDALDH1A1POLBKDM4EMAPT
SCHEMBL7355446 0.76 HTT (0.46) HPGDALDH1A1KDM4EMAPTHSD17B10
SCHEMBL5885171 0.75 ALDH1A1 (0.44) HPGDALDH1A1TP53KDM4EHSD17B10
SCHEMBL6320988 0.74 KMT2A (0.48) HPGDPOLBTP53GLAKMT2A
SCHEMBL182820 0.74 ALDH1A1 (0.49) HPGDALDH1A1POLBKDM4EMAPT
SCHEMBL13733997 0.73 ALDH1A1 (0.58) ADORA2AHPGDALDH1A1POLBSMPD1
SCHEMBL11946685 0.73 TAS1R3 (0.57) ADORA2AHPGDALDH1A1TP53GLA
SCHEMBL182690 0.73 MKNK1 (0.40) ADORA2AHPGDALDH1A1POLBGLA
SCHEMBL3034809 0.72 HPGD (0.49) HPGDALDH1A1POLBHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115617-B2 Amino-substituted pyrimidinyl derivatives and methods of use AMGEN INC. (US) 2006-10-03 US disclosed
US-6939874-B2 Substituted pyrimidinyl derivatives and methods of use AMGEN INC. (US) 2005-09-06 US disclosed
EP-1427421-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS Amgen Inc. (US) 2004-06-16 EP disclosed
WO-2003018021-A1 2,4-DISUBSTITUTED PYRIMIDINYL DERIVATIVES FOR USE AS ANTICANCER AGENTS AMGEN INC. (US) 2003-03-06 WO disclosed